NEULANDLABNSENeuland Laboratories Limited· PharmaceuticalsLowNeutral
Announced Wed, 20 Aug · 10:56 IST

Neuland Laboratories Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

NEULANDLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Neuland Laboratories has informed the stock exchanges that its management will participate in the Nuvama Non Deal Roadshow scheduled for August 25, 2025, in Hyderabad. The meetings will include both group sessions and one-on-one interactions with analysts and institutional investors. The disclosure has been made under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30). The company has noted that the schedule and participant list may change due to last-minute exigencies. The intimation has been signed by Sarada Bhamidipati, Company Secretary of the company.

Likely market impact

This is a routine investor relations disclosure with no immediate material impact on the stock. It signals continued engagement with the institutional investor community, which may help improve market visibility and analyst coverage.